Fungal Keratitis
Solutions
Online Inquiry

Fungal Keratitis

Fungal keratitis, or mycotic keratitis (MK), is an ocular infection that poses serious threats to eyesight stemming from various fungi. At Protheragen, we offer complete diagnostics and therapeutics development services for fungal keratitis. With the help of our advanced laboratories and skilled Protheragen scientists, we strive to tackle the problem using the best possible methods and solutions.

Introduction to Fungal Keratitis

Fungal keratitis is an advanced eye disease that greatly endangers the cornea and vision. It is mainly caused by filamentous fungi, for example, Aspergillus and Fusarium, along with Candida yeasts. In the absence of adequate therapeutics, it may lead to corneal ulceration, perforation, and blindness. Fungal keratitis is mostly observed in the tropical and subtropical climates due to factors such as high temperatures, humidity, and agriculture which increase the likelihood of corneal injury and infection. Presentation involves pain, redness, photophobia, weak vision, and tell-tale signs like feathery ulcer margins, satellite lesions, and hypopyon.

Microscopic examination of potassium hydroxide (KOH) wet mount corneal scraping (X10) showing fungal filaments.Fig.1 Microscopic examination of KOH wet mount corneal scrapping (X10) showing fungal filaments. (Awad R., et al., 2024)

Diagnostics Development for Fungal Keratitis

Microbiological Culture

Fungal keratitis is best diagnosed using gram culture. Corneal scrapes are taken and cultured with both selective and non-selective media. Blood agar as well as Sabouraud dextrose agar serve as common mediums. Macroscopic and microscopic examination of fungal growth confirms infection. Extraction facilitates the identification of the pathogen, permitting antifungal therapy to be tailored based on susceptibility testing.

Molecular Techniques

The diagnosis of fungal keratitis has been transformed profoundly with the introduction of rapid and ultra-sensitive detection of fungal DNA using polymerase chain reaction (PCR). Unlike culturing which takes days, PCR can identify specific fungal species within hours. This method is especially useful when culture results are negative but there is a strong clinical suspicion. Unfortunately, PCR does not allow antifungal susceptibility testing, and contamination resulting in false positive results need to be carefully controlled.

Direct Microscopy

Direct microscopy like the use of Gram stain, Giemsa stain, KOH, and KOH wet mounts are rapid methods for detecting fungal elements in corneal scraping. KOH wet mount is particularly useful in the visualization of hyphal and yeast forms of fungi. The sensitivity of direct microscopy is aided by the use of additional stains such as trypan blue which aid in staining fungal filaments thereby improving the visualization.

Artificial Intelligence

The advancement of technology has greatly aided in the AI diagnosis of fungal keratitis. Today, AI algorithms analyze clinical data alongside slit-lamp photographs and confocal microscope images, distinguishing fungal keratitis from other infections. In addition, these algorithms predict therapeutic outcomes enabling them to tailor therapeutics, therefore increasing the precision and efficacy of clinical decisions.

Therapeutics of Fungal Keratitis

Therapeutics Target Description Stage
Natamycin Fungal Elements First-line topical therapeutics for fungal keratitis. Applied hourly until improvement is noticed, then reduced to every two hours. Continued for 2 weeks after resolution of infection. Approved
Voriconazole Fungal Elements Broad-spectrum antifungal effective against filamentous and yeast fungi. Used topically or systemically, especially in cases resistant to natamycin. Approved
Amphotericin B Fungal Elements Effective against Candida but not Fusarium. Used topically or intravenously for severe infections. Approved
Econazole Fungal Elements Effective against filamentous fungi. Used topically as an alternative to natamycin. Approved
Fluconazole Fungal Elements Fungistatic agent used in combination with other antifungals for Candida or Aspergillus infections. Approved
Clotrimazole Fungal Elements Topical medication for fungal keratitis. Approved
Posaconazole Fungal Elements Broad-spectrum triazole used in cases resistant to natamycin and voriconazole. Approved
Echinocandins Fungal Cell Wall Group of antifungal drugs that cause fungal cell lysis through inhibition of (1,3)-D-glucan synthesis. Effective in refractory cases. Approved
Intrastromal Antifungal Injections Deep Stromal Infections Direct injection of antifungal agents (e.g., voriconazole, amphotericin B) into the corneal stroma to achieve high local drug concentrations. Approved
Intracameral Antifungal Injections Deep Stromal and Endothelial Infections Injection of antifungal agents into the anterior chamber for severe cases with deep stromal infiltration. Approved
Collagen Cross-Linking (CXL) Corneal Tissue Uses riboflavin and UV light to strengthen corneal tissue and has antimicrobial effects. It can be used as a standalone or adjunct therapy. Approved
Rose Bengal Photodynamic Antimicrobial Therapy (PDAT) Fungal Elements Uses rose bengal and green light to kill fungal organisms. Effective in cases resistant to other therapeutics. Approved

Disclaimer: Protheragen focuses on providing preclinical research services. This table is for information exchange purposes only. This table is not a treatment plan recommendation. For guidance on treatment options, please visit a regular hospital.

Our Services

At Protheragen, we understand that each client's needs are unique. Therefore, we offer customized services tailored to meet specific research and development requirements. Whether you need help with diagnostics development, therapeutics evaluation, or preclinical research, our team of experts is here to provide comprehensive support and guidance.

Protheragen is a leading provider of preclinical therapeutics development services for fungal keratitis. Our advanced diagnostics, innovative therapeutics, and customized services enable us to support clients in their quest to develop novel solutions for this sight-threatening condition. If you are interested in our services, please feel free to contact us.

Reference

  • Awad, Ramy, et al. "Fungal keratitis: diagnosis, management, and recent advances." Clinical Ophthalmology (2024): 85-106.